Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

890 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of a rapid response system and code status discussion as determinants of prognosis for critical inpatients: An observational study in a Japanese urban hospital.
Higashino M, Hiraoka E, Kudo Y, Hoshina Y, Kitamura K, Sakai M, Ito S, Fujimoto Y, Hiasa Y, Hayashi K, Fujitani S, Suzuki T. Higashino M, et al. Among authors: hiasa y. Medicine (Baltimore). 2021 Aug 13;100(32):e26856. doi: 10.1097/MD.0000000000026856. Medicine (Baltimore). 2021. PMID: 34397894 Free PMC article.
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals.
Watanabe T, Tokumoto Y, Joko K, Michitaka K, Horiike N, Tanaka Y, Hiraoka A, Tada F, Ochi H, Kisaka Y, Nakanishi S, Yagi S, Yamauchi K, Higashino M, Hirooka K, Morita M, Okazaki Y, Yukimoto A, Hirooka M, Abe M, Hiasa Y. Watanabe T, et al. Among authors: hiasa y. Sci Rep. 2023 Jun 2;13(1):8992. doi: 10.1038/s41598-023-36052-0. Sci Rep. 2023. PMID: 37268672 Free PMC article.
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy.
Watanabe T, Tokumoto Y, Ochi H, Mashiba T, Tada F, Hiraoka A, Kisaka Y, Tanaka Y, Yagi S, Nakanishi S, Sunago K, Yamauchi K, Higashino M, Hirooka K, Tange M, Yukimoto A, Morita M, Okazaki Y, Hirooka M, Abe M, Hiasa Y. Watanabe T, et al. Among authors: hiasa y. J Gastroenterol. 2024 Nov 15. doi: 10.1007/s00535-024-02174-z. Online ahead of print. J Gastroenterol. 2024. PMID: 39545995
Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma.
Hiraoka A, Otsuka Y, Kawasaki H, Izumoto H, Ueki H, Kitahata S, Aibiki T, Okudaira T, Yamago H, Miyamoto Y, Iwasaki R, Tomida H, Mori K, Miyata H, Tsubouchi E, Kishida M, Hirooka M, Abe M, Matsuura B, Ninomiya T, Mori I, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: hiasa y. J Gastroenterol Hepatol. 2018 Jun;33(6):1271-1276. doi: 10.1111/jgh.14058. Epub 2018 Jan 19. J Gastroenterol Hepatol. 2018. PMID: 29193248
Low Urine pH Is Associated with Non-alcoholic Fatty Liver Disease: A Community-based Cross-sectional Study.
Miyake T, Yoshida S, Yamamoto S, Furukawa S, Yoshida O, Kanzaki S, Senba H, Ishihara T, Koizumi M, Tokumoto Y, Hirooka M, Kumagi T, Abe M, Kitai K, Matsuura B, Hiasa Y. Miyake T, et al. Among authors: hiasa y. Intern Med. 2018 Oct 1;57(19):2799-2805. doi: 10.2169/internalmedicine.0167-17. Epub 2018 May 18. Intern Med. 2018. PMID: 29780107 Free PMC article.
Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker.
Hiraoka A, Kato M, Marui K, Murakami T, Onishi K, Adachi T, Matsuoka J, Ueki H, Yoshino T, Tsuruta M, Aibiki T, Okudaira T, Kuroda T, Iwasaki R, Suga Y, Miyata H, Ninomiya T, Hirooka M, Abe M, Matsuura B, Michitaka K, Hiasa Y. Hiraoka A, et al. Among authors: hiasa y. Cancer Med. 2021 Jun;10(11):3584-3592. doi: 10.1002/cam4.3908. Epub 2021 May 7. Cancer Med. 2021. PMID: 33960691 Free PMC article.
Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer.
Terao T, Kumagi T, Hyodo I, Yokota T, Azemoto N, Miyata H, Kuroda T, Ohno Y, Tanaka Y, Shibata N, Imamura Y, Kanemitsu K, Miyake T, Koizumi M, Hiasa Y; Ehime Pancreato-Cholangiology (EPOCH) Study Group. Terao T, et al. Among authors: hiasa y. Medicine (Baltimore). 2021 Oct 29;100(43):e27591. doi: 10.1097/MD.0000000000027591. Medicine (Baltimore). 2021. PMID: 34713835 Free PMC article.
Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non-viral infection: A Japanese multicenter observational study.
Hatanaka T, Kakizaki S, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Shimada N, Kawata K, Kosaka H, Tanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Naganuma A, Koizumi Y, Nakamura S, Joko K, Kaibori M, Iijima H, Hiasa Y, Kumada T; Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hatanaka T, et al. Among authors: hiasa y. Cancer Med. 2023 Mar;12(5):5293-5303. doi: 10.1002/cam4.5337. Epub 2022 Oct 13. Cancer Med. 2023. PMID: 36226511 Free PMC article.
Changes in characteristics of gastroenterology center inpatients in Japan because of rapidly aging society.
Fukunishi Y, Hiraoka A, Tada F, Fukumoto M, Matsuda T, Matsuoka K, Nakatani K, Yanagihara E, Saneto H, Izumoto H, Murakami T, Onishi K, Kitahata S, Kanemitsu-Okada K, Kawamura T, Kuroda T, Miyata H, Tsubouchi E, Hanaoka J, Watanabe J, Ohtani H, Yoshida O, Hirooka M, Abe M, Matsuura B, Ninomiya T, Hiasa Y. Fukunishi Y, et al. Among authors: hiasa y. J Gastroenterol Hepatol. 2024 Aug;39(8):1528-1534. doi: 10.1111/jgh.16557. Epub 2024 Apr 18. J Gastroenterol Hepatol. 2024. PMID: 38634347
890 results